SAN DIEGO–(Business enterprise WIRE)–DexCom, Inc. (NASDAQ: DXCM), the world wide leader in actual-time ongoing glucose monitoring, nowadays declared the advertising of Jereme Sylvain to the purpose of Govt Vice President and Main Economic Officer. In his expanded part, Mr. Sylvain will think accountability for Dexcom’s overall finance firm and report to Quentin Blackford, Main Working Officer.
Mr. Sylvain is an attained govt with extra than 20 yrs of knowledge in corporate finance and accounting roles at top healthcare technological innovation businesses. Since becoming a member of Dexcom, Mr. Sylvain has performed an instrumental function in the growth of the company’s world finance organization. Most not too long ago, he has served as Dexcom’s Senior Vice President, Finance and Main Accounting Officer given that March 2020.
“Since joining Dexcom, Jereme has regularly demonstrated his ability to support the business drive productive scale and processes even though also strengthening the finance staff,” said Kevin Sayer, Chairman, President and Chief Government Officer at Dexcom. “Jereme’s expanded management will allow Quentin to continue on to execute on our goals to scale the business enterprise. With the new establishment of Dexcom Ventures, Quentin will also now suppose duty for our approach and company progress features in addition to his present COO tasks.”
“I am honored to presume the CFO purpose and carry on the good work getting sophisticated by the Dexcom management crew and dedicated workforce,” stated Mr. Sylvain. “I consider in our mission to convey Dexcom CGM technology to a lot of far more persons throughout the planet, driving greater wellness and financial outcomes for our shoppers and building solid value generation for our shareholders.”
About Jereme Sylvain
Mr. Sylvain has served as our Senior Vice President, Finance and Main Accounting Officer considering that March 2020, and joined DexCom in September 2018 as our Vice President, Finance and Company Controller. Prior to becoming a member of Dexcom, Mr. Sylvain held numerous positions at NuVasive, Inc., such as Vice President, Corporate Controller and Main Accounting Officer from August 2016 to September 2018 and Vice President, Company Controller from March 2014 to August 2016. Prior to joining NuVasive, Mr. Sylvain held the job of Senior Director, Finance with Thermo Fisher Scientific, wherever he was dependable for international accounting for the life sciences methods group. Mr. Sylvain joined Thermo Fisher Scientific in February 2014, pursuing its acquisition of Life Systems Company. From July 2007 to February 2014, Mr. Sylvain held numerous finance and accounting roles at Everyday living Technologies and its predecessor, Invitrogen Corporation. Prior to joining Invitrogen, Mr. Sylvain worked for the community accounting agency Ernst & Younger LLP.
Mr. Sylvain received his Licensed Public Accounting license right after acquiring a B.A. in Finance from Arizona Point out College and a M.S. in Accountancy from the College of Notre Dame.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is establishing and marketing and advertising constant glucose monitoring systems for ambulatory use by persons with diabetes and by healthcare suppliers for the remedy of people with diabetic issues.
